Decreased neuronal cells with increased astrocytes in HIV-1 Tg rats. by Young-Eun Cho (325567)

Fructose diet decreases APAP hepatoxicity. by Sungjoon Cho (4385851)

Subjects:

Cooperativity decreases with the expression level of CheA. by Stephan Eismann (835052)

L665W decreased AR5A binding to H77/JFH1 particles and to the E1/E2 complex in H77/JFH1 infected cells, but did not alter receptor dependency. by Rodrigo Velázquez-Moctezuma (3776023)

Increased apoptosis and decreased necrosis after BCL-W and BCL2 and autophagy inhibition. by Anatasha C. Crawford (255140)

Decrease in adhesion during early development of <i>Dictyostelium discoideum</i>. by Marco Tarantola (102609)

G9a decreases Rhox5 expression. by Mayumi Sugimoto (151133)

G9a decreases Rhox5 expression. by Mayumi Sugimoto (151133)

L586W mutation decreases cyclic nucleotide affinity to the C-linker/CNBDs of HCN2 channels. by Sebastien Hayoz (388817)

(A) Decreasing CaMKII activity by KN-93 (high-3 µmol/L, low-0.5 µmol/L), AIP (high-10 µmol/L, low-2 µmol/L), or decreasing calmodulin activity by W-7 (high-50 µmol/L, low-20 µmol/L) decreases spontaneous AP firing rate (n = 10 for each drug), cAMP (n = 4 for each drug) and ATP (n = 5 for each drug). by Yael Yaniv (162548)

“…<p>The inactive KN-93 analog, KN-92 (3 µmol/L), has no significant effect on these measurements. A decrease in the spontaneous AP firing rate is associated with a decrease in cAMP that is linked to a decrease in ATP (B). …”

Inhibition of ABCG2 decreases SP cells, but not sphere-forming ability. by Noriko Kawai (6694010)

Subjects:

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

Low glucose induces a decrease in LAMP2 expression. by Delphine Balmer (458897)

MEK5 expression decreases ER signaling and confers endocrine resistance. by James W. Antoon (444010)

Overexpression of Lethe decreases ROS production in BMM. by Carlos Zgheib (311460)

BAL total lipid and lipid classes decreased in COPD correlating with FEV1. by Christina W. Agudelo (8415171)

OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

“…After 4 weeks, when the tumor size was approximately 100 mm³ (T₀) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”

Stx2 and SubAB decrease HGEC viability. by María M. Amaral (439445)

CMV infection decreases TER of polarized HCoEpiC. by Ekaterina Maidji (3797899)

Increased expression of Fz5 receptor matched with a decrease in NeuN immunoreactivity at 16w. by Carlos González-Fernández (2794207)